What is Molnupiravir?
Molnupiravir is an experimental medicine currently being studied to treat mild-to-moderate COVID-19. The drug is currently being tested, and its full risks have not been determined.
The FDA has approved the use of emergency molnupiravir to treat mild-to-moderate COVID-19 among people aged 18 and over.
- Have a mild to moderate COVID-19 diagnosis;
- Those at risk of severe COVID-19, including hospitalization and death
- For whom is COVID-19 not an option or not applicable?
Molnupiravir has not been approved for use.
- COVID-19 is a serious illness that requires hospitalization.
- Prevention before and after COVID-19 exposure;
- More than five consecutive days
Warnings
The FDA has approved the use of emergency molnupiravir to treat mild-to-moderate COVID-19 among people aged 18 and over.
Before you take this drug
Inform your doctor of any chronic or serious disease.
Molnupiravir can harm an unborn child if either the mother or father are taking this medication.
- Do not take molnupiravir while pregnant if you're a female. While taking this medication and for 4 days following your last dose, use birth control.
- Use an effective contraceptive if you're a male and your partner is or can become pregnant. Continue to use birth control at least three months after your last pill.
- Do not wait to tell your doctor if you become pregnant while using molnupiravir.
Before starting the treatment, you may be required to take a pregnancy test.
You may find your name on a registry for pregnant women to monitor the effect of molnupiravir.
You should not breastfeed for 4 days following your last dose or while taking this medication. You should throw away any collected milk if you are using a pump to breastfeed during this period. Do not give it to your child.
No one under the age of 18 is allowed to use this product.
How to take Molnupiravir?
Follow the instructions on your prescription label and read all medication guides or instruction sheets. Please read the instructions on your prescription and any medication guide or instruction sheet.
For 5 days, take four capsules of molnupiravir every 12 hours.
This medicine should be taken as soon as you can after a diagnosis of COVID-19 and no later than 5 days from the first symptoms.
Take molnupiravir either with food or without.
Do not open, crush, chew, or break the capsule.
Taking molnupiravir does not reduce your contagiousness. Continue to use infection-control methods, such as isolation, distancing from others, washing hands, wearing protective masks, disinfecting surfaces that you frequently touch, and not sharing items.
Molnupiravir's risks and side effects are still under investigation.
Details on dosage
Adult dose for COVID-19:
Only for investigational purposes
Take 800mg orally for five days, every 12 hours.
Comments:
The US FDA issued an Emergency Use Authorization (EUA) authorizing the emergency use of unapproved drug molnupiravir for treatment of mild to moderate coronavirus disease 2019 (COVID-19), including hospitalization or death in high-risk individuals who tested positive with direct severe acute respiratory syndrome coronavirus 2 testing; alternative COVID-19 treatments authorized by FDA were either unavailable or clinically inappropriate; although this drug was never intended for this use.ossible following the diagnosis of COVID-19 and no later than 5 days after the onset of symptoms.
The safety and effectiveness of using the product beyond five days have not been proven.
If hospitalization is necessary after beginning treatment, the patient can complete the 5-day course at the discretion of the health care provider.
Elderly patients do not require dosage adjustments.
For additional information, visit: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#coviddrugs.
Treatment of COVID-19 is mild or moderate for patients.
Positive results from direct SARS-CoV-2 virus testing.
Who are at high risk of progressing to COVID-19 severe, which may include hospitalization and death.
for whom alternative COVID-19 treatment options authorized by the US FDA are not accessible or clinically appropriate.
What happens if I miss the dose?
If you miss a dose by more than 10 hours, you should skip it. Never take two doses of the same medicine at once.
What happens if I overdose?
Call 1-800-222-1222 for poison help or seek immediate medical attention.
What should be avoided?
If your doctor prescribes any restrictions on foods, drinks, or activities, follow their instructions.
Side effects of Molnupiravir
If you experience any of the following symptoms of a molnupiravir allergy: difficulty breathing, hives, swelling in your lips, face, throat, or tongue, or hives, get emergency medical attention.
If you notice any symptoms that are new or getting worse, call your doctor.
Some of the most common side effects associated with molnupiravir include:
- Diarrhea, nausea;
There may be other side effects. For medical advice about side effects, call your physician directly or report them by calling the FDA at 1-800-FDA-1088.
Interaction with other drug
Other medications, such as prescription drugs, over-the-counter products, vitamins, and herbal remedies, may also affect molnupiravir. Inform your doctor of all the other medications you take.
